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ABSTRACT Nerve growth factor (NGF) promotes neuronal survival and differentiation by activating TrkA receptors. Similar
to other receptor tyrosine kinases, ligand-induced dimerization is thought to be required for TrkA receptor activation. To study
this process, we expressed TrkA receptors in Xenopus laevis oocytes and analyzed their response to NGF by using a
combination of functional, biochemical, and structural approaches. TrkA receptor protein was detected in the membrane
fraction of oocytes injected with TrkA receptor cRNA, but not in uninjected or mock-injected oocytes. Application of NGF to
TrkA receptor-expressing oocytes promoted tyrosine phosphorylation and activated an oscillating transmembrane inward
current, indicating that the TrkA receptors were functional. Freeze-fracture electron microscopic analysis demonstrated novel
transmembrane particles in the P-face (protoplasmic face) of oocytes injected with TrkA cRNA, but not in uninjected or mock
injected oocytes. Incubating TrkA cRNA-injected oocytes with the transcriptional inhibitor actinomycin D did not prevent the
appearance of these P-face particles or electrophysiological responses to NGF, demonstrating that they did not arise from
de novo transcription of an endogenous Xenopus oocyte gene. The appearance of these particles in the plasma membrane
correlated with responsiveness to NGF as detected by electrophysiological analysis and receptor phosphorylation, indicating
that these novel P-face particles were TrkA receptors. The dimensions of these particles (8.6  10 nm) were too large to be
accounted for by TrkA monomers, suggesting the formation of TrkA receptor oligomers. Application of NGF did not lead to
a discernible change in the size or shape of these TrkA receptor particles during an active response. These results indicate
that in Xenopus oocytes, NGF activates signaling via pre-formed TrkA receptor oligomers.
INTRODUCTION
Nerve growth factor (NGF) is required for the development
and maintenance of the nervous system. NGF initiates many
of its biological effects by activating TrkA tyrosine kinase
receptors in the plasma membrane (Barbacid, 1995; Klesse
and Parada, 1999; Kaplan and Miller, 2000). Similar to
other receptor tyrosine kinases, NGF is thought to induce
receptor dimerization as a first step for signal transduction
(Meakin and Shooter, 1991; Schlessinger and Ullrich,
1992). This hypothesis is supported by the bivalent nature of
NGF that can bring TrkA receptor monomers into close
proximity such that each monomer phosphorylates multiple
tyrosine residues on its partner, thereby initiating down-
stream signal transduction (Kaplan and Stephens, 1994;
Mcdonald et al., 1991; Meakin and Shooter, 1991; Schless-
inger and Ullrich, 1992). However, several studies have
shown that biological response can be elicited with mono-
valent ligands or a chimeric NGF/neurotrophin-4 dimer
(Maliartchouk et al., 2000a,b; Treanor et al., 1995). There-
fore, ligand binding per se may not be responsible for
receptor dimerization. In line with these observations, re-
cent studies of other receptor tyrosine kinases suggest that
1) tyrosine kinase receptors can form ligand-independent
oligomers on the plasma membrane of cells (Gadella and
Jovin, 1995; Wiseman and Petersen, 1999); 2) dimerization/
oligomerization of these receptor tyrosine kinases is neces-
sary but not sufficient to activate signaling; and 3) binding
of ligand induces rotational coupling of these pre-formed
receptor oligomers to initiate receptor transphosphorylation
and signal transduction (Jiang and Hunter, 1999; Burke et
al., 1997; Burke and Stern, 1998; Livnah et al., 1996, 1998,
1999; Remy et al., 1999).
To investigate the oligomeric state (i.e., monomer, dimer,
or larger size oligomer) of TrkA receptors and the possible
role of NGF binding in inducing oligomerization, we ex-
pressed TrkA receptors in Xenopus laevis oocytes and ex-
amined their response to NGF by using a combination of
functional, biochemical, and structural approaches. Two
properties made oocytes ideally suited for structure/function
studies. First, the plasma membrane of the oocyte contains
a low density of endogenous transmembrane proteins (200–
300/m2 instead of 2000/m2 in most cells), which al-
lows the identification of the exogenous proteins from the
size and shape of the newly inserted particles induced by
cRNA injection. Second, oocytes synthesize and transport
to the plasma membrane a large number of exogenous
channels and transporters as well as many of their geneti-
cally engineered mutants. While in the plasma membrane,
the exogenous proteins are characterized by electrophysio-
logical and optical methods before the same oocytes are
processed for electron microscopy (Eskandari et al., 1998,
1999, 2000; Zampighi et al., 1995, 1999). These properties
of the oocyte expression system provide a simple yet pow-
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erful approach to determine whether functional membrane
proteins are assembled as monomers, dimers, or larger size
oligomers in a heterologous cellular environment.
MATERIALS AND METHODS
cRNA preparation and oocyte microinjection
The carboxy-terminal FLAG-tagged TrkA receptor was generated by a
PCR strategy to insert two FLAG epitopes in tandem on the carboxy-
terminal (Mischel et al., 2001). A PCR reaction was done with the rat TrkA
cDNA as a template, using forward primer 5CA GGG ACT AGT GGT
CAA GAT GAT TGG A and reverse primer 5 CTT ATC ATC ATC ATC
CTT GTA ATC GCC CAG AAC GTC CAG G to amplify a fragment
encoding the last 405 basepairs of rat TrkA receptor coding sequence
(minus the stop codon) including the 5Spe1 site (part of the coding
sequence) and the first FLAG epitope on the 3 end. This product was then
used as a template for a second PCR reaction using the same forward
primer and a reverse primer encoding the second FLAG tag followed by a
stop codon and Xho1 restriction site 5CTG CTC GAG CTA CTT ATC
ATC ATC ATC CTT GTA ATC CTT ATC ATC ATC. The amplified
product was digested with Spe1 and Xho1 and subcloned into similarly
digested full-length TrkA in pGEMHE (a modified pGEM vector that
contains 5 and 3 Xenopus -globin untranslated sequences for RNA
stability (Liman et al., 1992; Mischel et al., 2001). TrkA was transcribed
using the T7 mMessage Machine from Ambion (Austin, TX). Transcripts
were purified using an RNAeasy kit purchased from QIAGEN Inc. (Va-
lencia, CA), analyzed on agarose gels, and quantitated by spectrophotom-
etry (and by densitometric comparison to RNA standards).
Mature Xenopus laevis oocytes (Dumont stage V–VI) were isolated,
defolliculated, and injected with 5 ng of TrkA cRNA. Oocytes were
maintained at 17–18°C in ND96 (in mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1
MgCl2, 5 HEPES, pH 7.5, and 1 g/ml ciprofloxacin, 6 g/ml ceftazidime,
and 1 g/ml gentamicin.
Immunoblot analysis
For analysis of TrkA expression, 10 oocytes microinjected with TrkA
cRNA (and 10 control oocytes) were manually homogenized in an ice-cold
solubilization buffer (65 mM Tris-HCl, 50 mM NaCl, 5 mM EDTA, 2%
Triton X-100, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM
phenylmethylsulfonyl fluoride, 5 g/ml aprotinin, 5 g/ml leupeptin, 1
mM sodium orthovanadate, 10 mM sodium fluoride, pH 7.5). Lysates were
incubated at 4°C for 1 h and the soluble phase was partitioned from the
insoluble and lipid phases by three rounds of centrifugation at 18370  g
for 5 min at 4°C. For preparation of a membrane fraction, oocytes were
manually homogenized in ice-cold homogenization buffer and samples
were centrifuged at 735  g for 5 min at 4°C. The pellet (containing the
membrane) was solubilized in 500 l of a buffer containing 130 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 2% Triton X-100 and 10 mM EDTA, 1
mM phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, 1 g/ml leupeptin,
and 1 mM sodium orthovanadate. Samples were pre-cleared with protein
A/G Sepharose beads (Pierce, Rockford, IL), and immunoprecipitated with
anti-FLAG M2 antibody (Stratagene, La Jolla, CA). Immunoprecipitates
were washed three times with 1 ml of solubilization buffer and protein was
recovered by boiling for 5 min in 3 Laemmli sample buffer. SDS-PAGE
was performed on 7.5% polyacrylamide gels. After transfer to nitrocellu-
lose membranes (Hybond, Amersham Pharmacia Biotech, Piscataway, NJ),
samples were blocked in TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1%
Tween 20, pH 8.0) with 5% non-fat dried milk and incubated with the
anti-FLAG M2 monoclonal antibody (Stratagene) at a concentration of 10
g/ml overnight at 4°C. After washing, blots were incubated with horse-
radish peroxidase (HRP) conjugated goat anti-mouse antibody (Promega,
Madison, WI) or HRP conjugated goat anti-rabbit antibody (Promega) at a
dilution of 1:5000 for 1–2 h at room temperature. After washing, bands
were visualized by incubating with Supersignal (Pierce), followed by
exposure to Kodak BIOMAX film (Eastman Kodak Company, Rochester,
NY). Experiments were repeated three times using independent oocytes.
For analysis of tyrosine phosphorylation, 100 ngml–1 of NGF (4 nM)
(Sigma, St. Louis, MO) was added to the media of 10 TrkA-expressing
oocytes and 10 control oocytes for 5 min at room temperature. Oocytes
were manually homogenized in ice-cold solubilization buffer, incubated for
1 h at 4°C, and centrifuged at 18370  g for 5 min at 4°C. Samples were
resolved electrophoretically for immunoblot analysis as mentioned above,
and incubated with anti-phosphotyrosine monoclonal antibody 4G10 (Up-
state Biotechnology, Lake Placid, NY). Blots were washed as above and
incubated with HRP conjugated goat anti-mouse antibody (Promega), and
visualized by using enhanced chemiluminescence (Amersham Pharmacia
Biotech). Experiments were repeated three times using independent
oocytes.
For analysis of endogenous NGF expression in oocytes, 20 uninjected
oocytes were incubated in 60 l of ND96 for 24 h. Oocytes was manually
homogenized in ice-cold solubilization buffer, solubilized and fractionated
as described above. Samples were separated electrophoretically for immu-
noblot analysis and incubated with anti-2.5S-NGF monoclonal antibody
(Sigma). For analysis of NGF expression in the oocyte culture medium, 20
l (one-third of total culture medium) was resolved electrophoretically for
immunoblot analysis.
Electrophysiology
Stage V–VI Xenopus laevis oocytes were isolated, defolliculated, injected
with TrkA cRNA (5–20 ng), and cultured for 2 days in Barth’s solution
(Umbach et al., 1990). Oocytes with resting potentials more negative than
50 mV were voltage-clamped using the two-electrode voltage clamp
method and an Axoclamp-2A amplifier (Axon Instruments, Foster City,
CA). The membrane potential was held at 60 mV and current measure-
ments were made at 20–22°C during bath application of NGF (100 ng
ml–1) in Barth’s solution. Data were recorded on a PrimeLine (Soltec, San
Fernando, CA) chart recorder and also stored on Axotape (Axon Instru-
ments) for analysis. The reversal potential of the NGF-evoked current was
estimated by stepping the holding potential to depolarizing potentials
during an active response (Umbach et al., 1990). Membrane capacitance
was determined at the beginning of each experiment by integrating (using
Clampfit, pCLAMP 6.0, Axon Instruments) the capacitive current elicited
by 10 and 20 mV depolarizing steps (30 ms) from the holding mem-
brane potential (Zampighi et al., 1999). Whole-cell capacitance is reported
as the mean calculated from at least six pulses per cell. Immediately
following electrophysiological measurements, oocytes were fixed in 4%
glutaraldehyde in 0.2 M sodium cacodylate (pH 7.4) (Zampighi et al.,
1999), and prepared for freeze-fracture electron microscopy (Eskandari et
al., 1998, 1999, 2000; Zampighi et al., 1999).
Freeze-fracture electron microscopy
The freeze-fracture structural data were collected from a total of eight
oocytes (3 TrkA-expressing oocytes treated with NGF, 3 TrkA-expressing
oocytes without NGF treatment, and 2 control uninjected oocytes). For
particle density determinations, images of protoplasmic (P) fracture faces
were digitized at a final magnification of 150,000. Particle densities were
determined by counting P-face particles from known areas of the plasma
membrane (NIH Image). For each oocyte, a minimum of 1000 particles
was counted from at least 10 m2 of plasma membrane. For measurement
of the dimensions of the freeze-fracture particles, particles were sampled
from two replicas from two oocytes. For construction of the frequency
histograms, the particle diameter was measured directly from the negatives
using a comparator (Nikon, Model 6c) at a final magnification of
1,000,000. The diameter measurements were plotted in a frequency
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histogram with a bin size of 1.0 nm and were fitted to a multiple Gaussian
function (Eskandari et al., 1998, 1999, 2000; Zampighi et al., 1999) (see
Fig. 3). All values are reported as mean  SE.
RESULTS
Expression of functional TrkA receptors in
Xenopus oocytes
As a prelude to the morphometric characterization of TrkA
receptors expressed in the plasma membrane of Xenopus
oocytes, we performed experiments to verify that functional
TrkA receptors were expressed in these cells. Prior inves-
tigations have documented, and we have confirmed (data
not shown), that Xenopus oocytes do not express either
TrkA or p75NTR receptors (Mischel et al., 2001; Nebreda
et al., 1991; Sehgal et al., 1988). Injection of Xenopus
oocytes with TrkA receptor cRNA led to the appearance of
a 140/110 kDa TrkA immunoreactive doublet, which was
not detected in uninjected (Fig. 1 A) or water injected
oocytes (data not shown) (Carriero et al., 1991; Mischel et
al., 2001; Nebreda et al., 1991). The 140 kDa band, which
represents the fully glycosylated membrane-bound receptor
(Barbacid, 1995; Meakin and Shooter, 1991) was also
present in a plasma membrane fraction isolated from TrkA
receptor cRNA-injected oocytes, but not in control oocytes
(Fig. 1 A) (Mischel et al., 2001). These TrkA receptors were
catalytically active, as demonstrated by tyrosine phosphor-
ylation of a number of proteins, including TrkA receptors,
in response to NGF (Fig. 1 B).
Further evidence that the 140/110 kDa immunoreactive
species of Fig. 1, A and B corresponded to functional TrkA
receptors came from the electrophysiological analysis of
oocytes expressing TrkA. In the absence of NGF the resting
electrophysiological properties of TrkA-expressing oocytes
did not differ from those of uninjected or water-injected
oocytes (not shown). Bath application of a saturating
concentration of NGF (100 ngml–1) elicited a slowly de-
veloping (10–15 s) oscillating inward current in oocytes
injected with TrkA receptor cRNA (Fig. 1 C). This NGF-
evoked current was not seen in control oocytes, even after
several minutes of exposure to this ligand (Fig. 1 C). Over-
all, 10 oocytes injected with TrkA receptor cRNA exhibited
responses similar to that seen in Fig. 1 C, while uninjected
oocytes (n  5) were uniformly unresponsive to NGF.
Freeze-fracture analysis of the plasma membrane
of oocytes
To investigate whether NGF induces oligomerization of
TrkA receptors, we used freeze-fracture electron micros-
copy to examine TrkA receptors expressed in the plasma
membrane of oocytes. First, we characterized the plasma
membrane particles of control oocytes. The P-face of con-
trol cells contained a low density of particles at 200  10
per m2 (Fig. 2 A). Consistent with previous observations
(Eskandari et al., 1998, 1999, 2000; Zampighi et al., 1999),
these endogenous P-face particles were circular in cross-
section with a mean diameter of 7.6  0.5 nm (Fig. 2 A).
Independent assessment of exoplasmic (E) face particles
revealed a density of 890  40 per m2 (Eskandari et al.,
1999). Water-injected oocytes exhibit a similar population
of P-face and E-face particles (data not shown). We then
examined the freeze-fracture particles of oocytes expressing
TrkA in the absence of exposure to NGF. Oocytes express-
ing the TrkA receptor revealed an additional population of
large particles in the P face of the plasma membrane (Fig. 2
B and Fig. 3, A and C). High magnification analysis
(1,000,000) of a selected subset of these particles (n 48)
demonstrated a rectangular shape with axes measuring 10
1.3 nm  8.6  0.5 nm (Figs. 2 B and 3); a/b  1.16 
0.05. These particles were randomly oriented in the xy-
FIGURE 1 Functional expression of TrkA receptors in the plasma mem-
brane of Xenopus oocytes. (A) Immunoblot analysis. Whole-cell lysates
(top panel) or membrane fractions (bottom panel) from oocytes microin-
jected with FLAG-tagged TrkA receptor cRNA (lane 1) or control oocytes
(lane 2) immunoprecipitated with an antibody against the FLAG epitope
and immunoblotted with the same antibody. (B) NGF stimulates tyrosine
phosphorylation of expressed TrkA receptors. Whole-cell lysates from
oocytes expressing TrkA, or control oocytes that were stimulated with
NGF (100 ngml–1) for 5 min were immunoblotted with anti-phosphoty-
rosine antibody (top panel). Lysates probed with anti-FLAG antibody
(bottom panel) demonstrate equal amounts of TrkA receptor protein in
oocytes with or without addition of NGF. The position of TrkA receptors
is marked with arrows. (C) In TrkA-expressing oocytes, NGF (100 ng
ml–1) activated a transient inward current with a notable oscillatory behav-
ior. The reversal potential for the NGF-evoked current was 29 mV (not
shown). In control oocytes there was no response to NGF. (D) Oocytes do
not secrete endogenous NGF. Lysates from cells (C) or one-third of the
total conditioned media (M) from control oocytes immunoblotted with
anti-NGF antibody. Immature NGF precursor (32 kDa, right arrowhead) is
seen in cells but not in the oocyte-bathing medium. No mature NGF is seen
in the cytoplasm or in the bathing medium of the oocytes. The anti-NGF
antibody recognizes the 2.5 s NGF () control (1 g of NGF; right arrow).
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plane. The presence of this new population of particles in
the plasma membrane led to an increase in the total density
of P-face particles to 340 particles/m2, an increase of
	140 particles/m2. No change in the density of E-face
particles was observed. This partitioning of the TrkA recep-
tors to the P-face of the membrane is consistent with other
heterologously expressed integral membrane proteins (Es-
kandari et al., 1998, 1999, 2000; Zampighi et al., 1995,
1999). To exclude the possibility that these particles re-
sulted from the expression of an endogenous membrane
protein initiated by the injection of TrkA receptor cRNA,
we cultured the oocytes in actinomycin D (0.1 mgml–1),
which inhibits transcription of endogenous genes (Umbach
and Gunderson, 1987). This treatment did not block the
appearance of the novel TrkA-induced particles, or electro-
physiological responses of oocytes to NGF (data not
shown). Therefore, the 10 8.6 nm freeze-fracture particles
that appeared after injection of TrkA cRNA arose specifi-
cally from translation of this foreign cRNA. Using whole-
cell capacitance measured in the same cell as an index of the
cell surface area (Zampighi et al., 1999), we estimated that
there were 
3.4  109 TrkA receptor particles present in
the plasma membrane of the oocytes analyzed.
Xenopus oocytes do not secrete NGF
NGF mRNA is present in Xenopus oocytes, and an imma-
ture NGF precursor protein has been observed in the cyto-
plasm of oocytes (Carriero et al., 1991). However, mature
NGF protein has not been detected in oocytes or their
secreted medium (Carriero et al., 1991; Wion et al., 1984).
Similarly, neurotrophic activity could not be detected in the
conditioned medium of oocytes or ovarian follicles (Sehgal
et al., 1988). We detected a 32 kDa immunoreactive band in
the cytoplasmic fraction of oocytes (Fig. 1 D) consistent
with the NGF precursor, as has previously been demon-
strated (Carriero et al., 1991; Wion et al., 1984). However,
the mature form of NGF was not detected in the cytoplasm
or culture medium of oocytes (Fig. 1 D). Similarly, no
mature NGF was detected in the culture medium from
water-injected or TrkA cRNA-injected oocytes (data not
shown). These findings argue that oocytes do not secrete
NGF, consistent with our electrophysiological result in
which the large NGF-evoked inward currents (Fig. 1 C)
were observed only after addition of NGF to the oocyte
bathing medium. For NGF to have provoked the responses
exemplified in Fig. 1 C, there must have been unliganded
TrkA receptors in the plasma membrane. Therefore, these
results suggest that the 10 8.6 nm TrkA receptor particles
in the plasma membrane (Figs. 2 and 3 A) correspond to the
inactive form of the receptor before NGF application.
NGF does not induce TrkA receptor aggregation
To determine whether NGF induces TrkA receptor aggre-
gation, we studied the size and shape of freeze-fracture
particles in oocytes fixed during an active response to the
ligand, as determined by the inward transmembrane current
(as illustrated by the response in Fig. 1 C). Simple visual
inspection showed that dimensions of the P and E freeze-
fracture particles remained unchanged upon addition of
NGF. This qualitative assessment was confirmed by com-
paring size frequency histograms of P-face particles in the
plasma membrane of NGF-treated and untreated oocytes
(Fig. 3, C and D). For the ligand-induced dimerization
hypothesis to be correct, the 10  8.6 nm TrkA receptor
particles would have to form substantially larger (20  8.6
nm or 10  17.2 nm) freeze-fracture particles. It can be
argued that the electrical response elicited from saturating
concentration of NGF might have resulted in the dimeriza-
tion of just a few receptor molecules. However, the pre-
dicted 20  8.6 nm or 10  17.2 nm diameter particles are
FIGURE 2 Freeze-fracture images of the P-face of
the plasma membrane of a control oocyte and an
oocyte expressing TrkA. In freeze-fracture images in-
tegral membrane proteins appear as “particles.” In the
control cell (A) the density of the P-face particles was
200  10/m2 (n  6 fracture faces). In the oocyte
expressing TrkA (B), the density increased to 340 
40/m2 (n  11 fracture faces). Using the density and
the total surface area of the same cell (obtained from
whole-cell capacitance), it is estimated that there were
3.4  109 TrkA receptors in the plasma membrane of
the cell in (B). Several endogenous particles in (A) are
enclosed in circles, and those arising from TrkA ex-
pression (B) are enclosed in squares. P denotes the
protoplasmic face of the plasma membrane. Scale bar
for A and B, 160 nm.
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so large with respect to the size distribution observed in
untreated oocytes that it would have been easily detected by
simple visual inspection of the large number of replicas
examined. Therefore, NGF does not alter the dimensions of
the TrkA receptor particles in the plasma membrane of the
oocyte during an active response.
DISCUSSION
It has been proposed that ligand-induced dimerization of
TrkA receptor monomers is a prerequisite for NGF signal-
ing (Jing et al., 1992; Meakin and Shooter, 1991; Schless-
inger and Ullrich, 1992). NGF, which is bivalent (Mcdonald
FIGURE 3 P-face of the plasma membrane of TrkA-expressing oocytes with or without exposure to NGF. The density of P-face particles is similar in
the TrkA-expressing oocytes regardless of exposure to NGF. In the absence of NGF (A) the particle density was 340  40/m2 (n  11 fracture faces),
and in the presence of NGF (B) the density was 340  90/m2 (n  9 fracture faces). Most importantly, no change occurred in the size and/or shape of
the TrkA particles after incubation of the cells with NGF (insets in A and B). (C) Size distribution of P-face particles in TrkA-expressing oocytes not exposed
to NGF. In addition to the population of endogenous particles, there was a predominant exogenous population that appeared only after expression of TrkA
(140  90 particles per m2). (D) The size distribution of the particles induced by TrkA expression was not altered if the cell was incubated in NGF before
preparation for freeze-fracture microscopy. The dimensions of TrkA receptor particles were the same in the absence and presence (100 ngml–1) of NGF
(10  1.3 nm  8.6  0.5 nm). Because the density of endogenous particles varies considerably between individual oocytes (150–350/m2) (11–15), the
difference in the relative frequency of endogenous particles in the TrkA injected oocytes with and without NGF is not significant. The histograms in (C)
and (D) were generated from a total of 8497 particles counted, 4625 particles in untreated TrkA-expressing oocytes, and 3862 particles in NGF-treated,
TrkA-expressing oocytes (250,000–500,000). High-magnification analysis (1,000,000), which demonstrated the rectangular shape of the particles, was
performed on a selected subset (n  48). Scale bar for (A) and (B), 80 nm. Scale bar for the insets in (A) and (B), 15 nm.
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et al., 1991), is thought to bridge two TrkA receptor mono-
mers, allowing each monomer to phosphorylate its partner.
The finding that NGF promotes chemical cross-linking of
TrkA receptors lends support to this hypothesis (Jing et al.,
1992; Meakin and Shooter, 1991; Schlessinger and Ullrich,
1992). However, evidence obtained from the use of mono-
valent ligands that cannot bridge TrkA receptors suggests
that ligand binding per se may not be responsible for recep-
tor dimerization (Maliartchouk et al., 2000a; Treanor et al.,
1995). To test this hypothesis, we combined electrophysio-
logical, biochemical, and freeze-fracture electron micros-
copy data to study the effect of NGF treatment on the
structure and function of TrkA receptors expressed in the
plasma membrane of oocytes.
Our data indicate that functional TrkA receptors were
expressed in the plasma membrane of oocytes injected with
TrkA cRNA. Injection of TrkA cRNA correlated with the
appearance of a 140/110 kDa doublet on immunoblot anal-
ysis. These TrkA receptors were catalytically active, as the
TrkA receptor protein exhibited an NGF-dependent increase
in tyrosine phosphorylation (Clary et al., 1994; Jing et al.,
1992; Kaplan and Stephens, 1994; Kaplan and Miller, 2000;
Segal and Greenberg, 1996). Electrophysiological analysis
indicated that addition of NGF to the bathing medium
evoked an oscillating inward current with a reversal poten-
tial of 29 mV, consistent with a chloride current. TrkA-
mediated activation of phospholipase C stimulates the re-
lease of ionized calcium from cytoplasmic stores (Kaplan
and Stephens, 1994; Klein et al., 1991; Loeb et al., 1994;
Mischel et al., 2001; Obermeier et al., 1993; Segal and
Greenberg, 1996), which activates endogenous calcium-
dependent chloride channels in oocytes (Callamaras and
Parker, 2000; Hartzell, 1996; Weber, 1999). The NGF-
evoked current was not seen in control oocytes, indicating
that the response to NGF was via the heterologously ex-
pressed TrkA receptors.
To visualize the TrkA receptors on the plasma membrane
we performed freeze-fracture electron microscopy. This
method splits plasma membranes to produce complemen-
tary P and E fracture faces, where integral membrane pro-
teins appear as “particles” in the fracture faces (Branton,
1966; Eskandari et al., 1998, 1999, 2000; Zampighi et al.,
1999). Proteins heterologously expressed in oocytes appear
as distinct P-face particles whose size and shape can be
distinguished from the endogenous integral membrane pro-
teins (Eskandari et al., 1998, 1999, 2000; Zampighi et al.,
1999). This technique can resolve proteins as small as 2.5
nm (Eskandari et al., 1999). In oocytes expressing the TrkA
receptor, a new population of rectangular P-face particles
(10  8.6 nm) was observed in the plasma membrane.
Several lines of evidence indicate that these freeze-fracture
particles represent the functional TrkA receptors in the
plasma membrane observed by electrophysiological and
biochemical methods. First, they were present in TrkA-
expressing oocytes, but not in mock-injected or uninjected
oocytes. Second, they partitioned only within the P-face of
the membrane, as has been demonstrated for a number of
other heterologously expressed transmembrane proteins
(Eskandari et al., 1998, 1999, 2000; Zampighi et al., 1995,
1999). Third, their presence in the plasma membrane cor-
related with responsiveness to NGF, as detected both by
electrophysiological analysis and receptor phosphorylation.
Finally, incubating oocytes with the transcriptional inhibitor
actinomycin D did not prevent the appearance of the P-face
particles or electrophysiological responses to NGF, indicat-
ing that they did not arise from de novo transcription of an
endogenous Xenopus oocyte gene.
Previously, we have studied integral membrane proteins
that consist of a multiple transmembrane domains con-
nected by small loops of extracellular domain (Eskandari et
al., 1998, 1999, 2000). Therefore, the cross-sectional area of
these freeze-fracture particles provided an index of the
number of transmembrane  helices of the proteins (1.4 
0.03 helix/nm3) (Eskandari et al., 1998, 1999). In contrast,
TrkA receptors have a single transmembrane domain and a
large globular extracellular domain (Holden et al., 1997;
Wiesmann et al., 1999). Because the freeze-fracture tech-
nique results in asymmetric cleavage of the integral mem-
brane protein, it is likely that the juxtamembrane region of
the extracellular domain contributes to the area of the
freeze-fracture particle. The TrkA receptor particles in the
P-face of the plasma membrane measured 8.6  10 nm.
After correcting for the thickness of the metal replica (2.4
nm on each side) (Eskandari et al., 1998, 1999, 2000), the
TrkA receptor particles were 6.2 0.5 nm 7.5 1.3 nm.
Because the crystal structure derived from the NGF binding
domain of two TrkA monomers complexed to NGF is 6.0
9.5 nm (Wiesmann et al., 1999), our data suggest that each
TrkA receptor particle consists of a minimum of two TrkA
receptors. Alternatively, if the extracellular domain of TrkA
does not contribute to the freeze-fracture particles, then each
TrkA receptor particle consists of larger aggregates of TrkA
receptors. In either case, the data indicate that TrkA recep-
tors are present on the plasma membrane as pre-formed
oligomers before NGF exposure.
To ensure that TrkA receptors were not oligomerized in
response to endogenously secreted NGF, we examined oo-
cytes and their culture media for evidence of NGF secretion.
Uninjected oocytes and oocytes injected with mRNA iso-
lated from submaxillary glands produce an immature 32
kDa NGF precursor protein, which is present in the cyto-
plasm (Carriero et al., 1991; Wion et al., 1984). However,
they do not secrete detectable mature NGF (Carriero et al.,
1991; Wion et al., 1984), prompting the hypothesis that
oocytes lack the machinery to process it (Wion et al., 1984).
We detected the 32 kDa NGF precursor protein in control
and TrkA cRNA-injected oocytes, but we did not detect any
NGF secretion (or more importantly, production of mature
NGF). Although we cannot formally dismiss the possibility
that the NGF precursor protein induces oligomerization of
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TrkA receptors before its insertion in the plasma membrane,
our data indicate that TrkA oligomerization is not sufficient
to activate signaling. Moreover, our data show that the
receptors expressed on the plasma membrane were compe-
tent to respond to NGF, suggesting that they were not
occupied by NGF precursor protein.
To further investigate our hypothesis that TrkA receptors
were pre-oligomerized, we proceeded to study the effect of
NGF application on TrkA receptor aggregation. NGF had
no discernible effect on the dimensions of the TrkA receptor
particles compared to the TrkA-expressing controls, which
had not been exposed to NGF. If NGF promoted aggrega-
tion of TrkA receptors to activate signaling (Jing et al.,
1992; Meakin and Shooter, 1991; Schlessinger and Ullrich,
1992), we should have detected a new population of parti-
cles of approximately twice the dimensions of the unligan-
ded receptors. The expected increase in the particle dimen-
sions is well within the limits of resolution of the freeze-
fracture replicas (
2.5 nm) (Eskandari et al., 1999) and
should have been evident by simple visual inspection of the
replicas. Our method of Gaussian fit to study the size
distribution of particles would not be able to distinguish a
difference in TrkA-expressing oocytes treated with or with-
out NGF if 5% of the TrkA receptors were responding to
NGF. However, the extent of TrkA receptor phosphoryla-
tion in response to bath application of NGF (Fig. 1 B)
strongly suggests that a sufficient number of TrkA receptors
were activated that would have enabled us to detect any
large particles due to NGF-mediated oligomerization. Fur-
thermore, the predicted freeze-fracture particles (20  17.2
nm) would be so large with respect to the size distribution
observed in the untreated oocytes that they would have been
easily identified by visual inspection, even at particle den-
sities below 1 per m2. Therefore, our results indicate that
NGF did not induce changes in the state of oligomerization
of TrkA receptors in the plasma membrane.
TrkA receptors were expressed at a relatively high den-
sity in oocytes compared to PC12 cells, which are a com-
mon model of TrkA signaling (Connolly et al., 1985; Klesse
and Parada, 1999). TrkA density in the oocyte plasma
membrane was 	140 per m2. If each particle represents a
TrkA dimer, then there are 	280 TrkA receptor monomers
per m2 in TrkA-expressing oocytes. In contrast, PC12
cells have a lower density of TrkA receptors. In PC12 cells,
2100–3000 TrkA binding sites have been estimated to be in
the plasma membrane per cell (Clary et al., 1994; Hemp-
stead et al., 1991). Because the surface area of undifferen-
tiated PC12 cells is 
290 m2 (Connolly et al., 1985), this
suggests that there are 7–10 TrkA binding sites per m2.
Therefore, we estimate that there is up to a 40-fold differ-
ence in the density of TrkA receptors in the plasma mem-
brane of oocytes relative to PC12 cells. It can be argued that
overexpression of TrkA receptors may contribute to their
oligomerization. Although we detected a low level of phos-
phorylation of these receptors in the absence of NGF, TrkA
tyrosine phosphorylation was dramatically increased by
NGF treatment. In addition, TrkA-expressing oocytes did
not reveal a large inward current in the absence of NGF, and
only exhibited this current in the presence of NGF. There-
fore, our data suggest that NGF activation of constitutive
TrkA receptor oligomers is physiological, and that TrkA
receptor oligomerization is insufficient for TrkA signaling.
This conclusion is further supported by the observation that
in oocytes, oligomerization is an intrinsic property of the
proteins that often occurs in the rough endoplasmic reticu-
lum and is not a function of density of receptors in the
plasma membrane (Eskandari et al., 1998, 1999, 2000;
Zampighi et al., 1999). For example, the Na/glucose co-
transporter is monomeric over a very wide density range
(100–3500/m2) (Eskandari et al., 1998); the neuronal glu-
tamate transporter (EAAT3) is pentameric (100–800/m2)
(Eskandari et al., 2000); and the gap junction hemichannel
connexin50 is hexameric (100–800/m2) (Zampighi et al.,
1999). These results suggest that oligomer formation in the
absence of ligand is an intrinsic property of TrkA receptors,
and is not sufficient to activate signaling. Therefore, TrkA
oligomers are fully competent to respond to NGF, and
initiate signaling after NGF binding.
The experimental evidence underlying the current model
of ligand-induced TrkA receptor dimerization is derived
primarily from chemical cross-linking studies (Jing et al.,
1992; Meakin and Shooter, 1991; Schlessinger and Ullrich,
1992). Similar cross-linking studies of the platelet derived
growth factor receptor  (PDGF-) and the epidermal
growth factor receptor (EGFR) also suggested that these
receptors exist in the plasma membrane as monomers that
dimerize upon addition of ligand (Cochet et al., 1988;
Heldin et al., 1989; Inui et al., 1993). However, the use of
new biophysical methods such as fluorescence resonance
energy transfer (FRET) and image correlation spectroscopy
(ICS) have challenged this model. In contrast to the chem-
ical cross-linking data, FRET analysis demonstrated that
EGF receptors exist in a pre-oligomerized state in the
plasma membrane of A431 cells (Gadella and Jovin, 1995),
and ICS analysis of non-transformed human fibroblasts
demonstrates that PDGF- receptors are pre-aggregated as
tetramers in the absence of ligand (Wiseman and Petersen.,
1999). Our finding that TrkA receptors are pre-oligomer-
ized is consistent with the these observations. In the future,
it will be important to apply these other biophysical tech-
niques to study TrkA aggregation in mammalian cells.
The hypothesis that TrkA is a constitutive oligomer in the
oocyte can explain several observations that are difficult to
reconcile with the notion that TrkA receptor dimerization is
sufficient for signaling. A dimer composed of NGF conju-
gated to NT-4 activates transphosphorylation of TrkA re-
ceptors and initiates biological responses, even though
NT-4 (at physiological concentrations) does not bind to
TrkA receptors (Treanor et al., 1995). This strongly sug-
gests the NGF/NT-4 heterodimer activates pre-formed TrkA
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receptor dimers. Similarly, small peptide monovalent li-
gands, can activate TrkA receptors and promote neurite
outgrowth in PC12 cells (Maliartchouk et al., 2000a) and
primary embryonic dorsal root ganglion (DRG) neurons
(Maliartchouk et al., 2000a), prompting the hypothesis that
small molecule peptidomimetics stabilize TrkA receptor
conformations that promote receptor activation.
Recent studies suggest that TrkA receptors must be in
close proximity to each other in the plasma membrane
before ligand binding. TrkA receptors bearing deletions and
point mutations within the first or second immunoglobulin-
like binding domains are constitutively phosphorylated and
biologically active in the absence of NGF (Arevalo et al.,
2000). The first immunoglobulin-like domain of TrkA ap-
pears to play a key role in regulating this ligand-indepen-
dent activation (Zaccaro et al., 2001). To explain these
findings, Arevalo et al. have suggested that there is a bal-
ance of attractive and repulsive forces between TrkA recep-
tor monomers in the membrane, which is altered by NGF
binding (or mutations within the ligand binding domain of
TrkA) (Arevalo et al., 2000). Our findings are also not at
odds with the observation of Woo and colleagues, who
demonstrated that NGF promotes dimerization of the solu-
ble extracellular domain of TrkA (Woo et al., 1998). Rather,
they argue for the importance of the transmembrane domain
in promoting ligand-independent TrkA oligomerization.
Consistent with this, most growth factor receptor tyrosine
kinases, including TrkA receptors, contain a conserved
transmembrane dimerization motif (Sternberg and Gullick,
1990) that may enable them to form inactive dimers in the
absence of ligand (Jiang and Hunter, 1999). Our study
suggests that TrkA receptors may be activated in a similar
fashion to other tyrosine kinases receptors, such as the
ErbB2/neu and EPO receptor, for which dimerization is
necessary, but not sufficient, to activate signaling (Burke et
al., 1997, 1998; Jiang and Hunter, 1999; Livnah et al., 1996,
1998, 1999; Remy et al., 1999). Precise rotational coupling
of receptor monomers induced by ligand-binding may be
required to initiate transphosphorylation of critical tyrosine
residues that are required for signal transduction (Jiang and
Hunter, 1999).
In summary, the unique characteristics of the Xenopus
oocyte expression system allowed us to use combined func-
tional, biochemical, and structural methods to study the role
of NGF binding in TrkA receptor dimerization. We con-
clude that, in the absence of NGF, TrkA receptors form
oligomers in the plasma membrane of oocytes. Therefore,
activation of signal transduction via the TrkA receptors
likely involves conformational changes that are induced by
NGF binding to pre-formed oligomeric receptor complexes.
In the future, it will be important to resolve the nature of the
conformational changes that accompany NGF binding, and
determine whether constitutive TrkA receptor complexes
are present in the plasma membrane of mammalian cells as
well.
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